OR WAIT null SECS
March 27, 2018
Major countries will be ranked based on the potential for biopharma market growth, innovation, and competitiveness.
March 26, 2018
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
March 23, 2018
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
March 22, 2018
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
March 19, 2018
Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture.
March 08, 2018
GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
March 06, 2018
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
February 20, 2018
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.